Amy Manning-Bog

4.3k total citations · 2 hit papers
29 papers, 3.2k citations indexed

About

Amy Manning-Bog is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Amy Manning-Bog has authored 29 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Amy Manning-Bog's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Nerve injury and regeneration (5 papers) and Lysosomal Storage Disorders Research (5 papers). Amy Manning-Bog is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Nerve injury and regeneration (5 papers) and Lysosomal Storage Disorders Research (5 papers). Amy Manning-Bog collaborates with scholars based in United States, Italy and Germany. Amy Manning-Bog's co-authors include Donato A. Di Monte, Alison L. McCormack, J. William Langston, Anthony L. Fink, Vladimir N. Uversky, Deborah A. Cory‐Slechta, Mona Thiruchelvam, Christine Thiffault, Jie Li and Sally K. Mak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Amy Manning-Bog

27 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

2002 602 citations Alison L. McCormack, Mona Thiruchelvam et al. Neurobiology of Disease profile →
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice

2002 507 citations Amy Manning-Bog, Alison L. McCormack et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Manning-Bog United States	19	1.9k	1.0k	947	837	494	29	3.2k
Chengsong Xie United States	31	1.7k 0.9×	1.0k 1.0×	1.2k 1.3×	1.8k 2.1×	700 1.4×	44	4.0k
Shankar J. Chinta United States	31	1.2k 0.6×	888 0.9×	916 1.0×	1.4k 1.6×	608 1.2×	56	3.6k
Marı́a José Casarejos Spain	32	1.1k 0.6×	1.1k 1.1×	662 0.7×	983 1.2×	519 1.1×	76	2.9k
Anita Sidhu United States	40	2.0k 1.1×	1.9k 1.9×	1.0k 1.1×	1.4k 1.7×	381 0.8×	86	4.0k
Chris McLendon United States	12	995 0.5×	602 0.6×	1.1k 1.2×	1.0k 1.2×	538 1.1×	16	2.6k
Jordi Bové Spain	24	2.1k 1.1×	1.5k 1.4×	946 1.0×	1.5k 1.8×	709 1.4×	35	4.3k
Mahmoud Kiaei United States	31	1.7k 0.9×	585 0.6×	762 0.8×	2.0k 2.3×	558 1.1×	48	3.9k
Ruth G. Perez United States	33	1.8k 1.0×	1.6k 1.5×	1.7k 1.8×	1.6k 1.9×	473 1.0×	56	4.2k
Pablo Ibáñez Spain	11	2.5k 1.3×	1.5k 1.4×	765 0.8×	1.1k 1.4×	767 1.6×	19	3.5k
Hong Yin United States	31	878 0.5×	1.5k 1.4×	603 0.6×	1.3k 1.6×	486 1.0×	59	3.6k

Countries citing papers authored by Amy Manning-Bog

Since Specialization

Citations

This map shows the geographic impact of Amy Manning-Bog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Manning-Bog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Manning-Bog more than expected).

Fields of papers citing papers by Amy Manning-Bog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Manning-Bog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Manning-Bog. The network helps show where Amy Manning-Bog may publish in the future.

Co-authorship network of co-authors of Amy Manning-Bog

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Manning-Bog. A scholar is included among the top collaborators of Amy Manning-Bog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Manning-Bog. Amy Manning-Bog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benjamin, Jonathan, Nicholas Higgins, Carl Millward, et al.. (2020). First-in-human phase Ib study of ATRC-101, an engineered version of a patient-derived antibody targeting a tumor-restricted ribonucleoprotein complex.. Journal of Clinical Oncology. 38(15_suppl). TPS3168–TPS3168.

Samaranch, Lluı́s, et al.. (2016). Axonal transport of AAV9 in nonhuman primate brain. Gene Therapy. 23(6). 520–526. 41 indexed citations

Woodling, Nathaniel S., Damien Colas, Qian Wang, et al.. (2016). Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice. Brain. 139(7). 2063–2081. 78 indexed citations

Pradhan, Suraj, et al.. (2016). Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease. Journal of Neuroimmune Pharmacology. 12(2). 292–304. 27 indexed citations

Chou, Vivian, et al.. (2014). Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease. Journal of Visualized Experiments. e50960–e50960. 10 indexed citations

Zahr, Natalie M., Carsten Alt, Dirk Mayer, et al.. (2014). Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy. Experimental Neurology. 261. 109–119. 17 indexed citations

Johansson, Jenny U., Suraj Pradhan, Nathaniel S. Woodling, et al.. (2013). Suppression of Inflammation with Conditional Deletion of the Prostaglandin E₂EP2 Receptor in Macrophages and Brain Microglia. Journal of Neuroscience. 33(40). 16016–16032. 74 indexed citations

Raman, Arjun V., et al.. (2013). Evidence of oxidative stress in young and aged DJ‐1‐deficient mice. FEBS Letters. 587(10). 1562–1570. 14 indexed citations

Chou, Vivian, Theodore R. Holman, & Amy Manning-Bog. (2012). Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. Neuroscience. 228. 73–82. 21 indexed citations

10.

Bellinger, Frederick P., Miyoko T. Bellinger, Lucia A. Seale, et al.. (2011). Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain. Molecular Neurodegeneration. 6(1). 8–8. 139 indexed citations

11.

Shchepinov, Mikhail S., Vivian Chou, Erik D. Pollock, et al.. (2011). Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. Toxicology Letters. 207(2). 97–103. 58 indexed citations

12.

Mak, Sally K., Alison L. McCormack, Amy Manning-Bog, Ana María Cuervo, & Donato A. Di Monte. (2010). Lysosomal Degradation of α-Synuclein in Vivo. Journal of Biological Chemistry. 285(18). 13621–13629. 278 indexed citations

13.

Manning-Bog, Amy, Birgitt Schüle, & J. William Langston. (2009). Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism. NeuroToxicology. 30(6). 1127–1132. 150 indexed citations

14.

Manning-Bog, Amy, W. Michael Caudle, Xiomara A. Perez, et al.. (2007). Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiology of Disease. 27(2). 141–150. 74 indexed citations

15.

Manning-Bog, Amy & J. William Langston. (2007). Model fusion: The next phase in developing animal models for parkinson’s disease. Neurotoxicity Research. 11(3-4). 219–240. 48 indexed citations

16.

Goers, John, Amy Manning-Bog, Alison L. McCormack, et al.. (2003). Nuclear Localization of α-Synuclein and Its Interaction with Histones. Biochemistry. 42(28). 8465–8471. 264 indexed citations

17.

Monte, Donato A. Di, Mitra Lavasani, & Amy Manning-Bog. (2002). Environmental Factors in Parkinson’s Disease. NeuroToxicology. 23(4-5). 487–502. 179 indexed citations

18.

McCormack, Alison L., Mona Thiruchelvam, Amy Manning-Bog, et al.. (2002). Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat. Neurobiology of Disease. 10(2). 119–127. 602 indexed citations breakdown →

19.

Manning-Bog, Amy, Alison L. McCormack, Jie Li, et al.. (2002). The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice. Journal of Biological Chemistry. 277(3). 1641–1644. 507 indexed citations breakdown →

20.

Bannon, Michael J., Amy Manning-Bog, C. W. M. Whitty, et al.. (2002). Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proceedings of the National Academy of Sciences. 99(9). 6382–6385. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact